Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday

Published 27/12/2023, 09:17
Updated 27/12/2023, 10:40
© Reuters.  Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Coherus BioSciences, Inc. (NASDAQ: CHRS) reported the FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv. Coherus BioSciences shares jumped 37.2% to $2.99 in the after-hours trading session.

Wall Street expects Bridgeline Digital, Inc. (NASDAQ: BLIN) to post a quarterly loss at 6 cents per share on revenue of $3.82 million after the closing bell. Bridgeline Digital shares gained 0.1% to $0.8494 in the after-hours trading session.

Ascent Industries Co. (NASDAQ: ACNT) reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal. Ascent Industries shares surged 7.4% to $8.69 in after-hours trading.

Check out our premarket coverage here

Procaps Group S.A. (NASDAQ: PROC) reported upbeat results for its third quarter. The company also said it now sees full-year 2023 net revenue growth of around 6% on a constant currency basis and an adjusted EBITDA of $77 million to $82 million. Procaps Group shares gained 1.3% to $4.03 in the after-hours trading session.

TOMI Environmental Solutions Inc (NASDAQ: TOMZ) filed for a shelf of up to 2.08 million shares of common stock by selling stockholders. TOMI Environmental Solutions shares 3.4% to $0.8893 in the after-hours trading session.

Check This Out: Beat Inflation With These 3 High-Yielding Dividend Stocks In Energy Sector From Wall Street's Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.